New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
07:47 EDTDSCODiscovery Labs receives new U.S. patent for pulmonary surfactant formulations
Discovery Laboratories announced it has received a patent issued by the United States Patent and Trademark Office entitled "Pulmonary Surfactant Formulations." The claims of the patent provide coverage for synthetic pulmonary surfactant compositions comprising a combination of a proprietary synthetic peptide and various lipids. The patent term expires in December 2028.
News For DSCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
08:05 EDTDSCODiscovery Labs awarded awarded $3M Phase II SBIR to develop KL4 surfactant
Discovery Laboratories announced that the Company has been awarded a Phase II Small Business Innovation Research Grant, or SBIR, valued at up to $3.0M from the National Institute of Allergy and Infectious Diseases, or NIAID, of the National Institutes of Health, or NIH, to support the development of the Company's aerosolized KL4 surfactant as a medical countermeasure to mitigate acute and chronic/late-phase radiation-induced lung injury. The company has been awarded $1.0M, and over the next three years may be awarded up to an additional $2.0M as part of this grant.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use